85
Views
7
CrossRef citations to date
0
Altmetric
Original Research

PRDX6 Overexpression Promotes Proliferation, Invasion, and Migration of A549 Cells in vitro and in vivo

, , , , & ORCID Icon
Pages 1245-1255 | Published online: 10 Feb 2021

References

  • Muñoz-Unceta N, Burgueño I, Jiménez E, Paz-Ares L. Durvalumab in NSCLC: latest evidence and clinical potential. Ther Adv Med Oncol. 2018;10:1758835918804151. doi:10.1177/175883591880415130344651
  • Socinski MA, Obasaju C, Gandara D, et al. Clinicopathologic features of advanced squamous NSCLC. J Thorac Oncol. 2016;11(9):1411–1422. doi:10.1016/j.jtho.2016.05.02427296106
  • Rolfo C, Caglevic C, Santarpia M, et al. Immunotherapy in NSCLC: a promising and revolutionary weapon. Adv Exp Med Biol. 2017;995:97–125. doi:10.1007/978-3-319-53156-4_528321814
  • Lu B, Chen XB, Hong YC, et al. Identification of PRDX6 as a regulator of ferroptosis. Acta Pharmacol Sin. 2019;40(10):1334–1342. doi:10.1038/s41401-019-0233-931036877
  • Jia G, Tan B, Ma J, Zhang L, Jin X, Li C. Prdx6 upregulation by curcumin attenuates ischemic oxidative damage via SP1 in rats after stroke. Biomed Res Int. 2017;2017:6597401. doi:10.1155/2017/659740128596967
  • Yun HM, Park KR, Park MH, et al. PRDX6 promotes tumor development via the JAK2/STAT3 pathway in a urethane-induced lung tumor model. Free Radic Biol Med. 2015;80:136–144. doi:10.1016/j.freeradbiomed.2014.12.02225582888
  • Zha X, Wu G, Zhao X, et al. PRDX6 protects ARPE-19 cells from oxidative damage via PI3K/AKT signaling. Cell Physiol Biochem. 2015;36(6):2217–2228. doi:10.1159/00043018626279427
  • Stewart DJ. Wnt signaling pathway in non-small cell lung cancer. J Natl Cancer Inst. 2014;106(1):djt356. doi:10.1093/jnci/djt35624309006
  • Cai J, Fang L, Huang Y, et al. Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC. Nat Commun. 2017;8:15870. doi:10.1038/ncomms1587028627514
  • Xu H, Lin D, Wang L, Liu N, Wang E. [Expression and mutation of β-catenin in non-small cell lung cancer]. Chin J Lung Cancer. 2004;7(5):409–413. doi:10.3779/j.issn.1009-3419.2004.05.08. Chinese.
  • Wang Y, Liu N, Dai S, Xu H, Wang E. [The relationship between expressions of β-catenin and TCF-4 in non-small cell lung cancer]. Chin J Lung Cancer. 2007;10(5):370–375. doi:10.3779/j.issn.1009-3419.2007.05.05. Chinese.
  • Yun HM, Park KR, Lee HP, et al. PRDX6 promotes lung tumor progression via its GPx and iPLA2 activities. Free Radic Biol Med. 2014;69:367–376. doi:10.1016/j.freeradbiomed.2014.02.00124512906
  • Rushefski M, Aplenc R, Meyer N, et al. Novel variants in the PRDX6 gene and the risk of acute lung injury following major trauma. BMC Med Genet. 2011;12:77. doi:10.1186/1471-2350-12-7721627785
  • Lee HL, Park MH, Son DJ, et al. Anti-cancer effect of snake venom toxin through down regulation of AP-1 mediated PRDX6 expression. Oncotarget. 2015;6(26):22139–22151. doi:10.18632/oncotarget.419226061816
  • Lin LZ, Wang SM, Zhou JX. [Effects of yiqi chutan recipe on tumor growth, survival time and expressions of PRDX-1 and PRDX-6 in Lewis lung carcinoma model mice with pi-deficiency syndrome]. Chin J Integr Trad West Med. 2011;31(1):99–103. Chinese.
  • Xu R, Pan J, Mei J, Zhang Q. Systematic characterization of prognostic values of peroxiredoxin family in gastric cancer. Biomed Res Int. 2020;2020:3948183. doi:10.1155/2020/394818332382548
  • Li Q, Wang N, Wei H, Li C, Wu J, Yang G. miR-24-3p regulates progression of gastric mucosal lesions and suppresses proliferation and invasiveness of N87 via peroxiredoxin 6. Digest Dis Sci. 2016;61(12):3486–3497. doi:10.1007/s10620-016-4309-927743162
  • Zhang J, Park HS, Kim JA, et al. Flavonoids identified from Korean Scutellaria baicalensis induce apoptosis by ROS generation and caspase activation on human fibrosarcoma cells. Am J Chin Med. 2014;42(2):465–483. doi:10.1142/s0192415x1450031124707875